MedPath

METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

86717

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Mar 31, 2022

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number86717
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

ESPIRAMICINAActive
Quantity: 1,5 MILLONES UI
Name: ESPIRAMICINA
METRONIDAZOLActive
Quantity: 250 mg
Name: METRONIDAZOL

ATC CLASSIFICATION (3)

J01R
J01RA
J01RA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.